 
        
        
        Saikosaponin D是从柴胡中分离纯化的天然产物,通过抑制 NF-κB 和 STAT3 信号通路来保护肝脏免受对乙酰氨基酚引起的毒性损伤,是 CCl4 引起的急性肝损伤的有效抑制剂,并对人肝癌细胞具有细胞毒性作用。在 A549 细胞中具有抗增殖作用,可能通过诱导 p53 和激活 Fas/FasL 凋亡系统实现。
 
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 产品名称 | STAT1 ↓ ↑ | STAT3 ↓ ↑ | STAT5 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nifuroxazide | ✔ | 98% | |||||||||||||||||
| Fludarabine | ✔ | 98% | |||||||||||||||||
| Artesunate | ✔ | 98% | |||||||||||||||||
| BP-1-102 | +++ STAT3, Kd: 504 nM | 99%+ | |||||||||||||||||
| Niclosamide | ++ STAT3, IC50: 0.7 μM | 98% | |||||||||||||||||
| Napabucasin | ✔ | 98% | |||||||||||||||||
| Cryptotanshinone | ++ STAT3, IC50: 4.6 μM | 98% | |||||||||||||||||
| Stattic | + STAT3, IC50: 5.1 μM | 98% | |||||||||||||||||
| NSC 74859 | + STAT3, IC50: 86 μM | 99%+ | |||||||||||||||||
| Ochromycinone | ✔ | 98% | |||||||||||||||||
| HO-3867 | ✔ | 97% | |||||||||||||||||
| C188-9 | ++++ STAT3, Kd: 4.7 nM | 99%+ | |||||||||||||||||
| HJC0152 | ✔ | 99% | |||||||||||||||||
| SH5-07 | ✔ | 95% | |||||||||||||||||
| SH-4-54 | ++++ STAT3, Kd: 300 nM | +++ STAT5, Kd: 464 nM | 99%+ | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Saikosaponin D, a natural product isolated and purified from the herb of Bupleurum chinense DC., is a SERCA inhibitor by inhibiting NF-κB and STAT3 signaling to protect against acetaminophen-induced hepatotoxicity and a potent inhibitor on acute hepatic injury by CCl4 and a potent cytotoxicity agent for human hepatocellular carcinoma cells, and has the antiproliferative effect in A549 cells that may be the induction of p53 and activity of the Fas/FasL apoptotic system. | 
| Concentration | Treated Time | Description | References | |
| Hippocampal neural progenitor cells (NPCs) | 5.13 µM (EC50) | 24 hours | SSd inhibited the survival and proliferation of NPCs and induced apoptosis by activating the NRAGE/NADE/NRIF apoptotic signaling pathway. | Clin Transl Med. 2020 Dec;10(8):e243 | 
| HepG2 cells | 7.5-15 µM | 24 hours | Induced autophagy and apoptosis, detected by GFP-LC3 puncta formation and Annexin V staining. | Cell Death Dis. 2013 Jul 11;4(7):e720 | 
| HepG2 cells | 7.5-15 µM | 24 hours | Induced autophagy and apoptosis, confirmed by GFP-LC3 puncta formation and Annexin V staining. | Cell Death Dis. 2013 Jul 11;4(7):e720 | 
| MCF-7 cells | 10 µM | 4 hours | Induced autophagy, detected by GFP-LC3 puncta formation and increased LC3-II protein levels. | Cell Death Dis. 2013 Jul 11;4(7):e720 | 
| HeLa cells | 10 µM | 4 hours | Induced autophagy, detected by GFP-LC3 puncta formation and increased LC3-II protein levels. | Cell Death Dis. 2013 Jul 11;4(7):e720 | 
| MCF-7 cells | 10 µM | 4 hours | Induced autophagy, confirmed by GFP-LC3 puncta formation and increased LC3-II protein expression. | Cell Death Dis. 2013 Jul 11;4(7):e720 | 
| HeLa cells | 10 µM | 4 hours | Induced autophagy, confirmed by GFP-LC3 puncta formation and increased LC3-II protein expression. | Cell Death Dis. 2013 Jul 11;4(7):e720 | 
| U937 cells | 1 µM | 48 hours | Inhibited cell proliferation, promoted apoptosis and cell-cycle arrest | Theranostics. 2021 Mar 31;11(12):5831-5846 | 
| MV4-11 cells | 1 µM | 48 hours | Inhibited cell proliferation, promoted apoptosis and cell-cycle arrest | Theranostics. 2021 Mar 31;11(12):5831-5846 | 
| Kasumi-1 cells | 1 µM | 48 hours | Inhibited cell proliferation, promoted apoptosis and cell-cycle arrest | Theranostics. 2021 Mar 31;11(12):5831-5846 | 
| NB4 cells | 1 µM | 48 hours | Inhibited cell proliferation, promoted apoptosis and cell-cycle arrest | Theranostics. 2021 Mar 31;11(12):5831-5846 | 
| HeLa cells | 15 µM | 6 hours | To assess the ability of SsD to modulate autophagy, it was found that SsD significantly inhibited the fusion of autophagosomes and lysosomes, leading to the accumulation of autophagosomes, increased lysosomal pH, and TFEB nuclear translocation. | Signal Transduct Target Ther. 2019 Feb 22;4:4 | 
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6N mice | Leukemia model | Intraperitoneal injection | 0.1 mg/kg or 0.5 mg/kg | 3 times per week for 3 weeks | Significantly inhibited leukemia progression, including reduced WBC count, decreased leukemic blasts in BM, reduced splenomegaly, inhibited lung metastasis and prolonged survival | Theranostics. 2021 Mar 31;11(12):5831-5846 | 
| C57BL/6J mice | Cognitive dysfunction model | Oral gavage | 16 mg/kg | Once daily for 14 consecutive days | SSd inhibited hippocampal neurogenesis and caused cognitive dysfunction by disrupting pro-BDNF/p75NTR and BDNF/TrkB signaling pathways. | Clin Transl Med. 2020 Dec;10(8):e243 | 
| Mice | Experimental autoimmune encephalomyelitis (EAE) model | Intragastric administration | 40 mg/kg | Once daily, starting from the day of immunization | To investigate the therapeutic effect of SSD on EAE, results showed that SSD significantly alleviated EAE symptoms | Nat Commun. 2021 Oct 27;12(1):6198 | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 1.28mL 0.26mL 0.13mL | 6.40mL 1.28mL 0.64mL | 12.80mL 2.56mL 1.28mL | |
| CAS号 | 20874-52-6 | 
| 分子式 | C42H68O13 | 
| 分子量 | 780.98 | 
| SMILES Code | CC1(C)CC[C@]2(CO3)[C@H](O)C[C@@]4(C)[C@]([C@]5([H])C=C[C@]43[C@]2([H])C1)(C)CC[C@@]([C@]5(C)CC6)([H])[C@@](CO)(C)[C@H]6O[C@@](O[C@H](C)[C@@H]7O)([H])[C@H](O)[C@H]7O[C@@]8([H])[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O8 | 
| MDL No. | MFCD09028095 | 
| 别名 | |
| 运输 | 蓝冰 | 
| InChI Key | KYWSCMDFVARMPN-LCSVLAELSA-N | 
| Pubchem ID | 107793 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C | 
| 溶解方案 | DMSO: 50 mg/mL(64.02 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1